Hundreds of lawsuits filed against some GLP-1 Makers over vision lossHundreds of lawsuits filed against some GLP-1 Makers over vision loss
Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned of the potential danger of vision loss. In statements, Novo Nordisk says, in part, they are “vigorously” fighting the lawsuits, saying they are “without merit,” while Eli Lilly says in part, it maintains “patient safety” is its Read More
GLP-1s linked to nutritional deficiencies in childrenGLP-1s linked to nutritional deficiencies in children
Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) within the first year—according to a new study published in the journal Childhood Obesity. Vitamin D deficiency was the most common, identified in 12.4% of children within one year of Read More
RNA therapy may help preserve muscle during GLP-1 weight lossRNA therapy may help preserve muscle during GLP-1 weight loss
GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when patients stop treatment, they often regain their weight—primarily as fat. GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when patients stop treatment, they often Read More
STAT+: Lilly’s breast cancer combo wins approvalSTAT+: Lilly’s breast cancer combo wins approval
The FDA just approved a new combination drug treatment for patients with an advanced form of breast cancer.
Researchers seek a role for Ghana’s traditional healers in breast cancer careResearchers seek a role for Ghana’s traditional healers in breast cancer care
In Ghana and many African countries, traditional medicine practitioners and faith healers play a prominent role in patient care. These practitioners use herbal remedies, spiritual healing or other practices rooted in local customs or knowledge passed down through generations. Trusted by their communities, they are accessible, affordable and regarded as more patient-centered than conventional or orthodox health care.
A single protein may help aggressive breast cancer spread to the brain and evade immune defensesA single protein may help aggressive breast cancer spread to the brain and evade immune defenses
Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast cancer spread to the brain and escape the body’s immune defenses.
A new AI-powered test offers more accurate prediction of breast cancer recurrence riskA new AI-powered test offers more accurate prediction of breast cancer recurrence risk
A new study published in the journal npj Breast Cancer demonstrates that an artificial intelligence (AI) model offers more accurate predictions of recurrence risk in patients with early-stage breast cancer than the widely used 21-gene Recurrence Score. This research, conducted by a team from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Caris Life Sciences, specifically targets hormone receptor-positive (HR+) and HER2-negative disease, the most common subtype of breast cancer, which accounts for about half of all breast cancer cases in the United States.
Early-adult BMI may lower postmenopausal breast cancer risk through breast densityEarly-adult BMI may lower postmenopausal breast cancer risk through breast density
Women with a higher body mass index (BMI) in early adulthood may have a lower risk of developing breast cancer after menopause because of lasting changes in the structure of their breast tissue, according to researchers at The University of Manchester and Manchester University NHS Foundation Trust.
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdosePopular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and Read More
This new diabetes pill burns fat without the downsides of OzempicThis new diabetes pill burns fat without the downsides of Ozempic
Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated. Scientists have Read More